North Shore Medical Labs INC.

North Shore Medical Labs INC. was paid $1.90M by Medicaid between Jan 2018 and Nov 2024, across 96 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 33% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New York

Rank by total paid#47 of 116

Median peer was paid$618K

This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	10,693	$21K
2019	19,187	$38K
2020	28,550	$183K
2021	52,065	$623K
2022	46,897	$360K
2023	61,508	$391K
2024incomplete	47,173	$288K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	33%	11,446	8,259	$628K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	9.3%	10,345	7,207	$177K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	7.5%	12,660	12,212	$143K
86769		5.7%	4,468	3,395	$109K
80050	General health panel	3.6%	3,624	3,578	$69K
82607		3.1%	10,462	10,328	$59K
82728		2.6%	8,125	8,006	$50K
83036	Hemoglobin; glycosylated (A1C)	2.6%	15,077	14,414	$49K
80061	Lipid panel	2.3%	16,296	15,439	$43K
86480		2.2%	1,413	1,383	$42K
84439		1.9%	9,245	8,949	$36K
80053	Comprehensive metabolic panel	1.7%	16,725	15,714	$32K

84 more codes

87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.6%	2,579	$30K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.4%	2,634	$27K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.3%	5,056	$25K
84443	Thyroid stimulating hormone (TSH)	1.2%	13,386	$23K
86803		1.1%	4,516	$22K
83550		1.1%	7,945	$21K
83540		1.1%	8,174	$21K
87340		1.1%	4,126	$20K
84480		1.0%	7,392	$20K
84153		1.0%	2,696	$19K
86706		1.0%	4,162	$19K
86709		<1%	3,705	$19K
83789		<1%	2,935	$18K
86696		<1%	1,931	$16K
86704		<1%	3,432	$16K
86140		<1%	7,189	$14K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	16,729	$13K
82746		<1%	1,800	$11K
83970		<1%	407	$10K
86695		<1%	1,656	$8K
82043		<1%	2,935	$8K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,756	$8K
84550		<1%	3,050	$7K
81000		<1%	4,083	$7K
86592		<1%	3,136	$6K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	151	$4K
84154		<1%	479	$4K
80074		<1%	143	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	324	$4K
86762		<1%	369	$3K
82540		<1%	1,297	$3K
86765		<1%	369	$3K
84403		<1%	258	$3K
83525		<1%	374	$3K
86141		<1%	354	$2K
87186		<1%	779	$2K
84156		<1%	878	$2K
84436		<1%	6,684	$2K
85730		<1%	536	$2K
86735		<1%	355	$2K
86038		<1%	540	$2K
85610		<1%	803	$2K
86787		<1%	298	$1K
87088		<1%	446	$1K
84146		<1%	96	$1K
83735		<1%	402	$1K
86431		<1%	436	$1K
84466		<1%	144	$998.32
82533		<1%	80	$925.50
84479		<1%	5,495	$751.95
85652		<1%	784	$632.39
80076		<1%	489	$483.32
84100		<1%	248	$465.91
82550		<1%	123	$417.23
86701		<1%	81	$365.32
80048	Basic metabolic panel (calcium, ionized)	<1%	201	$330.88
86304		<1%	29	$309.04
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	62	$302.25
82977		<1%	132	$244.10
85044		<1%	283	$242.89
83615		<1%	81	$228.81
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	54	$220.73
84270		<1%	43	$190.55
86300		<1%	16	$187.29
82785		<1%	41	$181.91
82784		<1%	41	$150.91
86705		<1%	125	$135.26
82787		<1%	41	$85.97
36415	Collection of venous blood by venipuncture	<1%	1,989	$75.70
84520		<1%	88	$60.21
84134		<1%	12	$58.56
83013		<1%	99	$56.58
84478		<1%	42	$54.07
82310		<1%	61	$48.51
82565		<1%	41	$34.78
80164		<1%	36	$30.00
82465		<1%	27	$27.72
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	12	$21.43
85027		<1%	62	$19.20
84481		<1%	28	$15.00
85007		<1%	220	$11.78
84155		<1%	28	$3.67
85009		<1%	54	$3.12
80321		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHEIKH, ABID (CEO)